Mange in Rabbits: An Ectoparasitic Disease with Zoonotic Potential

    Wafaa A. Abd El‐Ghany
    Image of study
    TLDR Mange in rabbits is a serious disease that can spread to humans and is treated with medications and supportive care.
    Mange in rabbits, primarily caused by the mites Sarcoptes scabiei, Psoroptes cuniculi, Cheyletiella parasitovorax, and Notoedres cati, is a significant parasitic disease that can lead to pruritus, alopecia, severe cachexia, and sometimes death. The disease, which has zoonotic potential, is transmitted through direct contact with infected animals or contaminated objects. Diagnosis is typically made through skin scraping and microscopic examination. While there is no commercial vaccine available, control of the disease relies on systemic and topical acaricides, natural products, and supportive care. The review aims to highlight the aspects of mange in rabbits, including infestation, clinical signs, public health implications, diagnosis, and control methods.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 5 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.
      [object Object]

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  450 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

    Similar Research

    5 / 1000+ results